Thymosin Alpha — Competitive Intelligence Brief

Thymosin Alpha (Thymosin Alpha) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immunomodulator. Area: Immunology.

marketed Immunomodulator Immunology Biologic

Target snapshot

Thymosin Alpha (Thymosin Alpha) — Second Affiliated Hospital, School of Medicine, Zhejiang University. Thymosin Alpha is an immunomodulatory peptide that enhances T-cell maturation and immune function by promoting thymic development and activation of immune cells.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Thymosin Alpha TARGET	Thymosin Alpha	Second Affiliated Hospital, School of Medicine, Zhejiang University	marketed	Immunomodulator
intralesional vitamin D3	intralesional vitamin D3	Combined Military Hospital Abbottabad	marketed	Vitamin D analog / immunomodulator	Vitamin D receptor (VDR)
Total Glucosides Paeony Capsules	Total Glucosides Paeony Capsules	Sun Yat-sen University	marketed	Herbal extract immunomodulator
MED ON plus	MED ON plus	IRCCS Istituto delle Scienze Neurologiche di Bologna	marketed	immunomodulator
Anaferon for Children	Anaferon for Children	Materia Medica Holding	marketed	Immunomodulator
Hydroxychloroquine Sulfate Regular dose	Hydroxychloroquine Sulfate Regular dose	Government of Punjab, Specialized Healthcare and Medical Education Department	marketed	Quinoline antimalarial and immunomodulator	Lysosomal pH regulation; toll-like receptors (indirect)
Intravenous immune globulin G	Intravenous immune globulin G	Rutgers, The State University of New Jersey	marketed	Immunoglobulin replacement therapy / Immunomodulator	Multiple (polyclonal IgG antibodies targeting various pathogens and self-antigens)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immunomodulator class)

1. Actavis Mid-Atlantic LLC · 1 drug in this class
2. Active Biotech AB · 1 drug in this class
3. Air Force Military Medical University, China · 1 drug in this class
4. Astellas Pharma Inc · 1 drug in this class
5. Bayer · 1 drug in this class
6. Beijing Children's Hospital · 1 drug in this class
7. Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 1 drug in this class
8. Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri · 1 drug in this class
9. Chang Gung Memorial Hospital · 1 drug in this class
10. ALK-Abelló A/S · 1 drug in this class